Global Molecular Diagnostics Cancer Market Insight 2020, Forecast to 2030
- Report Code : WOR2007391
- Published On: Aug, 2020
- Category : Healthcare & Pharma
- Pages : 167
-
The Molecular Diagnostics Cancer market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Molecular Diagnostics Cancer is projected to grow from US$ xx million in 2020, and is projected to reach xx by 2025, at a CAGR of xx% during the forecast period. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values are estimated based on manufacturers' revenue.
The report offers detailed coverage of Molecular Diagnostics Cancer industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Molecular Diagnostics Cancer by geography. The report splits the market size, by volume and value, on the basis of application type and geography.
In addition to this data, the report provides insight into drivers of market demand and strategies of suppliers. Key players are profiled, and their market shares in the global Molecular Diagnostics Cancer market are discussed.
The market is segmented by types:
Pharmacogenomic Diagnosis
Liquid Biopsy
Other
It can be also divided by applications:
Respiratory Cancer
Cancer of Digestive System
Cancer of Urinary System
Cancer of Circulatory System
Motor System Cancer
Reproductive System Cancer
Other
And this report covers the historical situation, present status and the future prospects of the global Molecular Diagnostics Cancer market for 2015-2025. In this report, we analyze global market from 5 geographies: Asia-Pacific, Europe, North America, Middle East & Africa, South America.
Finally, the report provides detailed profile and data information analysis of leading company.
Roche
Danaher
Siemens
Abbott Laboratories
ICON Plc
AstraZeneca
MDxHealth
Invitae
PlexBio
Thermo Fisher Scientific
Guardant Health
Biocartis
Bio-Techne
Merck
Foundation Medicine
10X Genomics
Biodesix
CytoTrack
GenomOncology
Luminex
Report Includes:
- xx data tables and xx additional tables
- An overview of global Molecular Diagnostics Cancer market
- An detailed key players analysis across regions
- Analyses of global market trends, with historical data, estimates for 2020 and projections of compound annual growth rates (CAGRs) through 2025
- Insights into regulatory and environmental developments
- Information on the supply and demand scenario and evaluation of technological and investment opportunities in the Molecular Diagnostics Cancer market
- Profiles of major players in the industry, including Roche, Danaher, Siemens, Abbott Laboratories, ICON Plc..
Research Objectives
To study and analyze the global Molecular Diagnostics Cancer consumption (value & volume) by key regions/countries, product type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Molecular Diagnostics Cancer market by identifying its various subsegments.
Focuses on the key global Molecular Diagnostics Cancer manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
To analyze the Molecular Diagnostics Cancer with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Molecular Diagnostics Cancer submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
-
With tables and figures helping analyze worldwide Global Molecular Diagnostics Cancer market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Global Molecular Diagnostics Cancer Market Report 2020, Forecast to 2025
1 Scope of the Study1.1 Molecular Diagnostics Cancer Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives
2 Molecular Diagnostics Cancer Industry Overview2.1 Global Molecular Diagnostics Cancer Market Size (Million USD) Comparison by Regions (2020-2025)
2.1.1 Molecular Diagnostics Cancer Global Import Market Analysis
2.1.2 Molecular Diagnostics Cancer Global Export Market Analysis
2.1.3 Molecular Diagnostics Cancer Global Main Region Market Analysis2.2 Market Analysis by Type
2.2.1 Pharmacogenomic Diagnosis
2.2.2 Liquid Biopsy
2.2.3 Other2.3 Market Analysis by Application
2.3.1 Respiratory Cancer
2.3.2 Cancer of Digestive System
2.3.3 Cancer of Urinary System
2.3.4 Cancer of Circulatory System
2.3.5 Motor System Cancer
2.3.6 Reproductive System Cancer
2.3.7 Other2.4 Global Molecular Diagnostics Cancer Revenue, Sales and Market Share by Manufacturer
2.4.1 Global Molecular Diagnostics Cancer Sales and Market Share by Manufacturer (2018-2020)
2.4.2 Global Molecular Diagnostics Cancer Revenue and Market Share by Manufacturer (2018-2020)
2.4.3 Global Molecular Diagnostics Cancer Industry Concentration Ratio (CR5 and HHI)
2.4.4 Top 5 Molecular Diagnostics Cancer Manufacturer Market Share
2.4.5 Top 10 Molecular Diagnostics Cancer Manufacturer Market Share
2.4.6 Date of Key Manufacturers Enter into Molecular Diagnostics Cancer Market
2.4.7 Key Manufacturers Molecular Diagnostics Cancer Product Offered
2.4.8 Mergers & Acquisitions Planning2.5 Molecular Diagnostics Cancer Historical Development Overview
2.6 Market Dynamics
2.6.1 Market Opportunities
2.6.2 Market Risk
2.6.3 Market Driving Force
2.6.4 Porter's Five Forces Analysis
2.7 Coronavirus Disease 2019 (Covid-19): Molecular Diagnostics Cancer Industry Impact
2.7.1 How the Covid-19 is Affecting the Molecular Diagnostics Cancer Industry
2.7.2 Molecular Diagnostics Cancer Business Impact Assessment - Covid-19
2.7.3 Market Trends and Molecular Diagnostics Cancer Potential Opportunities in the COVID-19 Landscape
2.7.4 Measures / Proposal against Covid-19
3 Upstream and Downstream Market Analysis3.1 Upstream Analysis
3.1.1 Macro Analysis of Upstream Markets
3.1.2 Key Players in Upstream Markets
3.1.3 Upstream Market Trend Analysis
3.1.4 Molecular Diagnostics Cancer Manufacturing Cost Analysis3.2 Downstream Market Analysis
3.2.1 Macro Analysis of Down Markets
3.2.2 Key Players in Down Markets
3.2.3 Downstream Market Trend Analysis
3.2.4 Sales Channel, Distributors, Traders and Dealers
4 Global Molecular Diagnostics Cancer Market Size Categorized by Regions4.1 Global Molecular Diagnostics Cancer Revenue, Sales and Market Share by Regions
4.1.1 Global Molecular Diagnostics Cancer Sales and Market Share by Regions (2015-2020)
4.1.2 Global Molecular Diagnostics Cancer Revenue and Market Share by Regions (2015-2020)4.2 Europe Molecular Diagnostics Cancer Sales and Growth Rate (2015-2020)
4.3 APAC Molecular Diagnostics Cancer Sales and Growth Rate (2015-2020)
4.4 North America Molecular Diagnostics Cancer Sales and Growth Rate (2015-2020)
4.5 South America Molecular Diagnostics Cancer Sales and Growth Rate (2015-2020)
4.6 Middle East & Africa Molecular Diagnostics Cancer Sales and Growth Rate (2015-2020)
5 Europe Molecular Diagnostics Cancer Market Size Categorized by Countries5.1 Europe Molecular Diagnostics Cancer Sales, Revenue and Market Share by Countries
5.1.1 Europe Molecular Diagnostics Cancer Sales by Countries (2015-2020)
5.1.2 Europe Molecular Diagnostics Cancer Revenue by Countries (2015-2020)
5.1.3 Germany Molecular Diagnostics Cancer Sales and Growth Rate (2015-2020)
5.1.4 UK Molecular Diagnostics Cancer Sales and Growth Rate (2015-2020)
5.1.5 France Molecular Diagnostics Cancer Sales and Growth Rate (2015-2020)
5.1.6 Russia Molecular Diagnostics Cancer Sales and Growth Rate (2015-2020)
5.1.7 Italy Molecular Diagnostics Cancer Sales and Growth Rate (2015-2020)
5.1.8 Spain Molecular Diagnostics Cancer Sales and Growth Rate (2015-2020)5.2 Europe Molecular Diagnostics Cancer Revenue (Value) by Manufacturers (2018-2020)
5.3 Europe Molecular Diagnostics Cancer Sales, Revenue and Market Share by Type (2015-2020)
5.3.1 Europe Molecular Diagnostics Cancer Sales Market Share by Type (2015-2020)
5.3.2 Europe Molecular Diagnostics Cancer Revenue and Revenue Share by Type (2015-2020)5.4 Europe Molecular Diagnostics Cancer Sales Market Share by Application (2015-2020)
6 Asia-Pacific Molecular Diagnostics Cancer Market Size Categorized by Countries6.1 Asia-Pacific Molecular Diagnostics Cancer Sales, Revenue and Market Share by Countries
6.1.1 Asia-Pacific Molecular Diagnostics Cancer Sales by Countries (2015-2020)
6.1.2 Asia-Pacific Molecular Diagnostics Cancer Revenue by Countries (2015-2020)
6.1.3 China Molecular Diagnostics Cancer Sales and Growth Rate (2015-2020)
6.1.4 Japan Molecular Diagnostics Cancer Sales and Growth Rate (2015-2020)
6.1.5 Korea Molecular Diagnostics Cancer Sales and Growth Rate (2015-2020)
6.1.6 India Molecular Diagnostics Cancer Sales and Growth Rate (2015-2020)
6.1.7 Southeast Asia Molecular Diagnostics Cancer Sales and Growth Rate (2015-2020)
6.1.8 Australia Molecular Diagnostics Cancer Sales and Growth Rate (2015-2020)6.2 Asia-Pacific Molecular Diagnostics Cancer Sales and Revenue (Value) by Manufacturers (2018-2020)
6.3 Asia-Pacific Molecular Diagnostics Cancer Sales, Revenue and Market Share by Type (2015-2020)
6.3.1 Asia-Pacific Molecular Diagnostics Cancer Sales Market Share by Type (2015-2020)
6.3.2 Asia-Pacific Molecular Diagnostics Cancer Revenue and Revenue Share by Type (2015-2020)6.4 Asia-Pacific Molecular Diagnostics Cancer Sales and Market Share by Application (2015-2020)
7 North America Molecular Diagnostics Cancer Market Size Categorized by Countries7.1 North America Molecular Diagnostics Cancer Sales, Revenue and Market Share by Countries
7.1.1 North America Molecular Diagnostics Cancer Sales by Countries (2015-2020)
7.1.2 North America Molecular Diagnostics Cancer Revenue by Countries (2015-2020)
7.1.3 United States Molecular Diagnostics Cancer Sales and Growth Rate (2015-2020)
7.1.4 Canada Molecular Diagnostics Cancer Sales and Growth Rate (2015-2020)
7.1.5 Mexico Molecular Diagnostics Cancer Sales and Growth Rate (2015-2020)7.2 North America Molecular Diagnostics Cancer Revenue (Value) by Manufacturers (2018-2020)
7.3 North America Molecular Diagnostics Cancer Sales, Revenue and Market Share by Type (2015-2020)
7.3.1 North America Molecular Diagnostics Cancer Sales Market Share by Type (2015-2020)
7.3.2 North America Molecular Diagnostics Cancer Revenue and Revenue Share by Type (2015-2020)7.4 North America Molecular Diagnostics Cancer Sales Market Share by Application (2015-2020)
8 South America Molecular Diagnostics Cancer Market Size Categorized by Countries8.1 South America Molecular Diagnostics Cancer Sales, Revenue and Market Share by Countries
8.1.1 South America Molecular Diagnostics Cancer Sales by Countries (2015-2020)
8.1.2 South America Molecular Diagnostics Cancer Revenue by Countries (2015-2020)
8.1.3 Brazil Molecular Diagnostics Cancer Sales and Growth Rate (2015-2020)8.2 South America Molecular Diagnostics Cancer Revenue (Value) by Manufacturers (2018-2020)
8.3 South America Molecular Diagnostics Cancer Sales, Revenue and Market Share by Type (2015-2020)
8.3.1 South America Molecular Diagnostics Cancer Sales Market Share by Type (2015-2020)
8.3.2 South America Molecular Diagnostics Cancer Revenue and Revenue Share by Type (2015-2020)8.4 South America Molecular Diagnostics Cancer Sales Market Share by Application (2015-2020)
9 Middle East and Africa Molecular Diagnostics Cancer Market Size Categorized by Countries9.1 Middle East and Africa Molecular Diagnostics Cancer Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Molecular Diagnostics Cancer Sales by Countries (2015-2020)
9.1.2 Middle East and Africa Molecular Diagnostics Cancer Revenue by Countries (2015-2020)
9.1.3 GCC Countries Molecular Diagnostics Cancer Sales and Growth Rate (2015-2020)
9.1.4 Turkey Molecular Diagnostics Cancer Sales and Growth Rate (2015-2020)
9.1.5 Egypt Molecular Diagnostics Cancer Sales and Growth Rate (2015-2020)
9.1.6 South Africa Molecular Diagnostics Cancer Sales and Growth Rate (2015-2020)9.2 Middle East and Africa Molecular Diagnostics Cancer Revenue (Value) by Manufacturers (2018-2020)
9.3 Middle East and Africa Molecular Diagnostics Cancer Sales, Revenue and Market Share by Type
9.3.1 Middle East and Africa Molecular Diagnostics Cancer Sales Market Share by Type (2015-2020)
9.3.2 Middle East and Africa Molecular Diagnostics Cancer Revenue and Revenue Share by Type (2015-2020)9.4 Middle East and Africa Molecular Diagnostics Cancer Sales Market Share by Application (2015-2020)
10 Global Molecular Diagnostics Cancer Market Segment by Type10.1 Global Molecular Diagnostics Cancer Revenue, Sales and Market Share by Type (2015-2020)
10.1.1 Global Molecular Diagnostics Cancer Sales and Market Share by Type (2015-2020)
10.1.2 Global Molecular Diagnostics Cancer Revenue and Market Share by Type (2015-2020)10.2 Pharmacogenomic Diagnosis Sales Growth Rate and Price
10.2.1 Global Pharmacogenomic Diagnosis Sales Growth Rate (2015-2020)
10.2.2 Global Pharmacogenomic Diagnosis Price (2015-2020)10.3 Liquid Biopsy Sales Growth Rate and Price
10.3.1 Global Liquid Biopsy Sales Growth Rate (2015-2020)
10.3.2 Global Liquid Biopsy Price (2015-2020)10.4 Other Sales Growth Rate and Price
10.4.1 Global Other Sales Growth Rate (2015-2020)
10.4.2 Global Other Price (2015-2020)
11 Global Molecular Diagnostics Cancer Market Segment by Application11.1 Global Molecular Diagnostics CancerSales Market Share by Application (2015-2020)
11.2 Respiratory Cancer Sales Growth Rate (2015-2020)
11.3 Cancer of Digestive System Sales Growth Rate (2015-2020)
11.4 Cancer of Urinary System Sales Growth Rate (2015-2020)
11.5 Cancer of Circulatory System Sales Growth Rate (2015-2020)
11.6 Motor System Cancer Sales Growth Rate (2015-2020)
11.7 Reproductive System Cancer Sales Growth Rate (2015-2020)
11.8 Other Sales Growth Rate (2015-2020)
12 Market Forecast for Molecular Diagnostics Cancer12.1 Global Molecular Diagnostics Cancer Revenue, Sales and Growth Rate (2020-2025)
12.2 Molecular Diagnostics Cancer Market Forecast by Regions (2020-2025)
12.2.1 Europe Molecular Diagnostics Cancer Market Forecast (2020-2025)
12.2.2 APAC Molecular Diagnostics Cancer Market Forecast (2020-2025)
12.2.3 North America Molecular Diagnostics Cancer Market Forecast (2020-2025)
12.2.4 South America Molecular Diagnostics Cancer Market Forecast (2020-2025)
12.2.5 Middle East & Africa Molecular Diagnostics Cancer Market Forecast (2020-2025)12.3 Molecular Diagnostics Cancer Market Forecast by Type (2020-2025)
12.3.1 Global Molecular Diagnostics Cancer Sales Forecast by Type (2020-2025)
12.3.2 Global Molecular Diagnostics Cancer Market Share Forecast by Type (2020-2025)12.4 Molecular Diagnostics Cancer Market Forecast by Application (2020-2025)
12.4.1 Global Molecular Diagnostics Cancer Sales Forecast by Application (2020-2025)
12.4.2 Global Molecular Diagnostics Cancer Market Share Forecast by Application (2020-2025)
13 Analysis of Molecular Diagnostics Cancer Industry Key Manufacturers13.1 Roche
13.1.1 Company Details
13.1.2 Product Information
13.1.3 Roche Molecular Diagnostics Cancer Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.1.4 Main Business Overview
13.1.5 Roche News13.2 Danaher
13.2.1 Company Details
13.2.2 Product Information
13.2.3 Danaher Molecular Diagnostics Cancer Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.2.4 Main Business Overview
13.2.5 Danaher News13.3 Siemens
13.3.1 Company Details
13.3.2 Product Information
13.3.3 Siemens Molecular Diagnostics Cancer Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.3.4 Main Business Overview
13.3.5 Siemens News13.4 Abbott Laboratories
13.4.1 Company Details
13.4.2 Product Information
13.4.3 Abbott Laboratories Molecular Diagnostics Cancer Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.4.4 Main Business Overview
13.4.5 Abbott Laboratories News13.5 ICON Plc
13.5.1 Company Details
13.5.2 Product Information
13.5.3 ICON Plc Molecular Diagnostics Cancer Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.5.4 Main Business Overview
13.5.5 ICON Plc News13.6 AstraZeneca
13.6.1 Company Details
13.6.2 Product Information
13.6.3 AstraZeneca Molecular Diagnostics Cancer Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.6.4 Main Business Overview
13.6.5 AstraZeneca News
13.7 MDxHealth
13.7.1 Company Details
13.7.2 Product Information
13.7.3 MDxHealth Molecular Diagnostics Cancer Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.7.4 Main Business Overview
13.7.5 MDxHealth News
13.8 Invitae
13.8.1 Company Details
13.8.2 Product Information
13.8.3 Invitae Molecular Diagnostics Cancer Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.8.4 Main Business Overview
13.8.5 Invitae News
13.9 PlexBio
13.9.1 Company Details
13.9.2 Product Information
13.9.3 PlexBio Molecular Diagnostics Cancer Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.9.4 Main Business Overview
13.9.5 PlexBio News13.10 Thermo Fisher Scientific
13.10.1 Company Details
13.10.2 Product Information
13.10.3 Thermo Fisher Scientific Molecular Diagnostics Cancer Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.10.4 Main Business Overview
13.10.5 Thermo Fisher Scientific News
13.11 Guardant Health
13.11.1 Company Details
13.11.2 Product Information
13.11.3 Guardant Health Molecular Diagnostics Cancer Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.11.4 Main Business Overview
13.11.5 Guardant Health News
13.12 Biocartis
13.12.1 Company Details
13.12.2 Product Information
13.12.3 Biocartis Molecular Diagnostics Cancer Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.12.4 Main Business Overview
13.12.5 Biocartis News
13.13 Bio-Techne
13.13.1 Company Details
13.13.2 Product Information
13.13.3 Bio-Techne Molecular Diagnostics Cancer Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.13.4 Main Business Overview
13.13.5 Bio-Techne News
13.14 Merck
13.14.1 Company Details
13.14.2 Product Information
13.14.3 Merck Molecular Diagnostics Cancer Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.14.4 Main Business Overview
13.14.5 Merck News
13.15 Foundation Medicine
13.15.1 Company Details
13.15.2 Product Information
13.15.3 Foundation Medicine Molecular Diagnostics Cancer Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.15.4 Main Business Overview
13.15.5 Foundation Medicine News
13.16 10X Genomics
13.16.1 Company Details
13.16.2 Product Information
13.16.3 10X Genomics Molecular Diagnostics Cancer Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.16.4 Main Business Overview
13.16.5 10X Genomics News
13.17 Biodesix
13.17.1 Company Details
13.17.2 Product Information
13.17.3 Biodesix Molecular Diagnostics Cancer Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.17.4 Main Business Overview
13.17.5 Biodesix News
13.18 CytoTrack
13.18.1 Company Details
13.18.2 Product Information
13.18.3 CytoTrack Molecular Diagnostics Cancer Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.18.4 Main Business Overview
13.18.5 CytoTrack News
13.19 GenomOncology
13.19.1 Company Details
13.19.2 Product Information
13.19.3 GenomOncology Molecular Diagnostics Cancer Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.19.4 Main Business Overview
13.19.5 GenomOncology News13.20 Luminex
13.20.1 Company Details
13.20.2 Product Information
13.20.3 Luminex Molecular Diagnostics Cancer Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.20.4 Main Business Overview
13.20.5 Luminex News
14 Research Findings and Conclusion
15 Appendix
-
The Global Molecular Diagnostics Cancer Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
A large number of Global Global Molecular Diagnostics Cancer players are focusing on individualized and innovative technologies that will provide the necessary impetus for profit and growth in the coming years.
Global Molecular Diagnostics Cancer has a wide range of applications, including
It is expected that the Global Molecular Diagnostics Cancer Market will reach USD XX million by 2029.
In addition to the Global Molecular Diagnostics Cancer Market share analysis by competitors, the report also includes chapters on the HHI Index, CR4, and CR8 to characterize the concentration rate and competitive character of the Global Molecular Diagnostics Cancer Market.
The Global Molecular Diagnostics Cancer analysis provides high-level qualitative commentary on market dynamics, including information on growth drivers, influential trends, challenges, and opportunities.
